Browse the evidence

The incidence of obesity-related glomerulopathy has increased 10-fold in recent years.

Increased awareness and screening for kidney issues in obese patients is essential.

Consumption of cow’s milk is associated with risks of fracture, obesity, cardiovascular disease, allergies, and various cancers.

Practitioners should consider both the potential benefits and risks of cow's milk consumption in dietary recommendations.

Fifteen problems across seven domains of nutrition and health are present.

Understanding these problems can help guide future research and interventions in nutrition.

Classification systems embody socio-cultural elements and subjective terms.

Practitioners should consider the cultural context when interpreting food classification systems.

Fatty acids can reshape the bioavailability of eicosanoids and other lipid mediators.

Recognizing how fatty acids affect lipid mediators can inform dietary choices for managing inflammation.

Cognitive scores were lower with increasing BF percentage and VAT.

Monitoring body fat percentage and visceral fat may be important for cognitive health.

Insulin resistance (IR) is a cardinal feature of type 2 diabetes mellitus (T2DM) and contributes to elevated cardiovascular disease (CVD) risk.

Addressing insulin resistance is crucial in managing T2DM and reducing CVD risk.

Predisposing risk factors for antipsychotic-induced weight gain (AIWG) include lack of prior AP exposure, sex, and age.

Clinicians should consider these risk factors when prescribing antipsychotics.

Epicardial adipose tissue (EAT) may contribute to the pathophysiology observed in HFpEF.

Understanding the role of EAT may help in developing targeted therapies for HFpEF.

Pharmacological interventions may attenuate the metabolic and inflammatory changes seen in EAT.

These pharmacological options may be considered in managing EAT-related cardiac dysfunction.

The gut microbiome may contribute to the development of obesity in humans.

Practitioners should consider the gut microbiome as a potential factor in obesity management.

A comprehensive redefinition of obesity in Asian Indians is needed beyond BMI criteria.

Practitioners should consider factors beyond BMI when diagnosing obesity in Asian Indians.

Stage 2 obesity requires excess waist circumference or waist-to-height ratio, along with symptoms or comorbid conditions.

Practitioners should assess waist measurements and related symptoms for obesity classification.

The refined framework aims to enhance precision in identifying obesity and its health risks.

Practitioners can use this framework to better assess obesity-related health risks.

The decision tree yields an AUC of 0.898 for phenotyping PCOS.

Clinicians can utilize this decision tree for effective phenotyping of PCOS.

The decision tree aims to improve PCOS management by reducing multiple blood tests and physician workload.

This decision tree could streamline the diagnostic process for PCOS, making it more efficient for healthcare providers.

The statistical power for non-inferiority was 91%, indicating a strong probability of validity.

The high statistical power suggests that the findings are reliable and not due to chance.

Different studies report conflicting results regarding the beneficial role of Blautia in obesity.

Practitioners should be aware of the mixed evidence regarding Blautia's role in obesity when considering interventions.

Only one study reported mild adverse events related to exercise training.

Exercise training is generally safe for individuals with type 2 diabetes, with minimal risk of adverse events.

Consumption of cherries may help to attenuate pain and decrease blood concentrations of biomarkers linked to skeletal muscle degradation.

Incorporating cherries into the diet may benefit individuals looking to reduce muscle degradation and pain.

Cherry anthocyanins may represent a potential non-pharmacological remedy for cardiometabolic diseases.

Cherries may be recommended as a dietary addition for managing cardiometabolic health.

Patients with incident heart failure had 5.6% higher serum branched-chain amino acids (BCAAs) than those without heart failure (median 639.3 vs 605.2 μmol/L; P = .01).

Higher levels of BCAAs may indicate an increased risk of heart failure in patients with type 2 diabetes.

Serum BCAAs had a positive linear association with incident heart failure (hazard ratio [HR] 1.22 per-SD increase).

Monitoring BCAA levels may help assess heart failure risk in type 2 diabetes patients.

Circulating levels of BCAAs are independently associated with incident heart failure in patients with type 2 diabetes.

Understanding BCAA levels could be crucial for managing heart failure risk in type 2 diabetes patients.